Nab Paclitaxel 100

Nab-Paclitaxel Injection
Nab-Paclitaxel Injection (Nanoparticle Albumin-Bound Paclitaxel) is an advanced formulation of paclitaxel designed to improve drug delivery and reduce solvent-related toxicity. It is widely used in modern oncology protocols for the treatment of various solid tumors and offers enhanced tumor penetration with improved tolerability.
Product Details
Generic Name: Nab-Paclitaxel
Dosage Form: Injection (Sterile lyophilized powder for suspension)
Route of Administration: Intravenous (IV infusion)
Therapeutic Class: Antineoplastic Agent (Taxane)
Indications
Nab-Paclitaxel Injection is indicated for the treatment of:
Breast cancer
Non-small cell lung cancer
Pancreatic cancer
Ovarian cancer
Other solid tumors as prescribed by an oncologist
Mechanism of Action
Nab-Paclitaxel stabilizes microtubules and inhibits their disassembly during cell division. The albumin-bound nanoparticle formulation facilitates enhanced drug transport into tumor cells, resulting in effective inhibition of cancer cell proliferation.
Key Benefits
Solvent-free formulation (no Cremophor EL)
Improved drug delivery to tumor tissue
Reduced hypersensitivity reactions
No routine premedication required
Widely accepted in global oncology treatment protocols
Dosage & Administration
Dosage is determined by the oncologist based on body surface area (BSA), cancer type, and treatment protocol. Nab-Paclitaxel should be administered only under the supervision of qualified healthcare professionals.
Storage Conditions
Store below 25°C
Protect from light
Do not freeze
Precautions
For hospital and oncology clinic use only
Regular monitoring of blood counts is advised
Use with caution in patients with hepatic impairment
Regulatory Status
Prescription Drug (Rx only)